Toshiba Medical’s Innovative MR Theater Helps Clinicians Enhance Patient Comfort

TUSTIN, Calif., Dec. 12, 2016 – Patients undergoing MR exams will find a relaxing environment with Toshiba Medical’s new MR Theater. Creating an immersive virtual experience for patients, the new MR Theater gives patients a visual focal point to distract them from the exam, encouraging them to relax and stay still, enabling clinicians to produce efficient, high-quality imaging.

            Available on Toshiba Medical’s Vantage GalanTM 3T and Vantage TitanTM 1.5T/cS Edition, the MR Theater projects peaceful, virtual reality images onto a dome-shaped screen inside the bore. The images move with the patient table for continuous display and the visual experience helps clinicians put their patients at ease.

Combined with Toshiba Medical’s PianissimoTM quiet scan technology, which helps reduce acoustic noise during the MR exam, patients are able to listen to in-ear audio as the MR Theater provides continuous projections for a truly engaging experience.

“Toshiba Medical’s new MR Theater helps our customers address some of the biggest challenges they face with MR imaging, claustrophobia and patient anxiety,” said Dominic Smith, senior director, CT, PET/CT, and MR Business Units, Toshiba America Medical Systems, Inc. “By putting patients at ease, clinicians can complete MR exams quickly and capture the high-quality images they need for accurate diagnosis and treatment, all while increasing patient satisfaction.”

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit Toshiba Medical’s website at www.medical.toshiba.com.

Around the web

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

AI-enabled coronary plaque assessments deliver significant value, according to late-breaking data presented at TCT. These AI platforms have gained considerable momentum in recent months, receiving expanded Medicare coverage in addition to a new Category I CPT code.

Trimed Popup
Trimed Popup